Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26


Measuring differential treatment benefit across marker specific subgroups: The choice of outcome scale.

Satagopan JM, Iasonos A.

Contemp Clin Trials. 2017 Feb 22. pii: S1551-7144(16)30093-3. doi: 10.1016/j.cct.2017.02.007. [Epub ahead of print]


Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry.

Wen W, Shu XO, Guo X, Cai Q, Long J, Bolla MK, Michailidou K, Dennis J, Wang Q, Gao YT, Zheng Y, Dunning AM, García-Closas M, Brennan P, Chen ST, Choi JY, Hartman M, Ito H, Lophatananon A, Matsuo K, Miao H, Muir K, Sangrajrang S, Shen CY, Teo SH, Tseng CC, Wu AH, Yip CH, Simard J, Pharoah PD, Hall P, Kang D, Xiang Y, Easton DF, Zheng W.

Breast Cancer Res. 2016 Dec 8;18(1):124.


Bayesian joint ordinal and survival modeling for breast cancer risk assessment.

Armero C, Forné C, Rué M, Forte A, Perpiñán H, Gómez G, Baré M.

Stat Med. 2016 Dec 10;35(28):5267-5282. doi: 10.1002/sim.7065. Epub 2016 Aug 14.


Quantifying Treatment Benefit in Molecular Subgroups to Assess a Predictive Biomarker.

Iasonos A, Chapman PB, Satagopan JM.

Clin Cancer Res. 2016 May 1;22(9):2114-20. doi: 10.1158/1078-0432.CCR-15-2517.


Using the Lorenz Curve to Characterize Risk Predictiveness and Etiologic Heterogeneity.

Mauguen A, Begg CB.

Epidemiology. 2016 Jul;27(4):531-7. doi: 10.1097/EDE.0000000000000499.


Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography.

Keller BM, McCarthy AM, Chen J, Armstrong K, Conant EF, Domchek SM, Kontos D.

BMC Cancer. 2015 Mar 18;15:143. doi: 10.1186/s12885-015-1159-3.


Assessment of a Four-View Mammographic Image Feature Based Fusion Model to Predict Near-Term Breast Cancer Risk.

Tan M, Pu J, Cheng S, Liu H, Zheng B.

Ann Biomed Eng. 2015 Oct;43(10):2416-28. doi: 10.1007/s10439-015-1316-5. Epub 2015 Apr 8.


Characterising the epigenome as a key component of the fetal exposome in evaluating in utero exposures and childhood cancer risk.

Ghantous A, Hernandez-Vargas H, Byrnes G, Dwyer T, Herceg Z.

Mutagenesis. 2015 Nov;30(6):733-42. doi: 10.1093/mutage/gev010. Epub 2015 Feb 26. Review.


Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer.

Aktas B, Sorkin M, Pusztai L, Hofstatter EW.

Eur J Cancer Prev. 2016 Jan;25(1):3-8. doi: 10.1097/CEJ.0000000000000124.


Statistical interactions and Bayes estimation of log odds in case-control studies.

Satagopan JM, Olson SH, Elston RC.

Stat Methods Med Res. 2017 Apr;26(2):1021-1038. doi: 10.1177/0962280214567140. Epub 2015 Jan 12.


Breast density and parenchymal texture measures as potential risk factors for Estrogen-Receptor positive breast cancer.

Keller BM, Chen J, Conant EF, Kontos D.

Proc SPIE Int Soc Opt Eng. 2014 Mar 27;9035:90351D.


Estimating Risk with Time-to-Event Data: An Application to the Women's Health Initiative.

Liu D, Zheng Y, Prentice RL, Hsu L.

J Am Stat Assoc. 2014 Jun 1;109(506):514-524.


Clinical trial design for testing the stem cell model for the prevention and treatment of cancer.

Reddy RM, Kakarala M, Wicha MS.

Cancers (Basel). 2011 Jun 20;3(2):2696-708. doi: 10.3390/cancers3022696.


Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.

Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, Lane DS, Johnson KC, Wactawski-Wende J, Chen C, Qi L, Yasmeen S, Newcomb PA, Prentice RL.

J Natl Cancer Inst. 2013 Apr 17;105(8):526-35. doi: 10.1093/jnci/djt043. Epub 2013 Mar 29.


Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies.

Chatterjee N, Wheeler B, Sampson J, Hartge P, Chanock SJ, Park JH.

Nat Genet. 2013 Apr;45(4):400-5, 405e1-3. doi: 10.1038/ng.2579. Epub 2013 Mar 3.


Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study.

Pastor-Barriuso R, Ascunce N, Ederra M, Erdozáin N, Murillo A, Alés-Martínez JE, Pollán M.

Breast Cancer Res Treat. 2013 Feb;138(1):249-59. doi: 10.1007/s10549-013-2428-y. Epub 2013 Feb 3.


The risk of developing invasive breast cancer in Hispanic women : a look across Hispanic subgroups.

Banegas MP, Leng M, Graubard BI, Morales LS.

Cancer. 2013 Apr 1;119(7):1373-80. doi: 10.1002/cncr.27896. Epub 2012 Dec 7.


Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study).

Gao F, Machin D, Chow KY, Sim YF, Duffy SW, Matchar DB, Goh CH, Chia KS.

BMC Cancer. 2012 Nov 19;12:529. doi: 10.1186/1471-2407-12-529.

Supplemental Content

Support Center